Osteoarthritis year in review 2014: Genetics and genomics

Osteoarthritis and Cartilage

Volumn 22, Issue 12, 2014, Pages 2017-2024

  Tsezou, A ^a  

^a UNIVERSITY OF THESSALY   (Greece)

Author keywords

Epigenetics; Functional genomics; Genetics; MicroRNAs; Osteoarthritis; Transcriptomics

Indexed keywords

GROWTH DIFFERENTIATION FACTOR 5; MICRORNA; MICRORNA 125; MICRORNA 148A; MICRORNA 21; MIRNA 127B; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

CARTILAGE; CARTILAGE CELL; CROSS LINKING; DNA METHYLATION; EPIGENETICS; GENE EXPRESSION; GENETICS; GENOMICS; HUMAN; OSTEOARTHRITIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; REVIEW; SYNOVIUM; DNA MICROARRAY;

DNA METHYLATION; EPIGENOMICS; GENOMICS; HUMANS; MICRORNAS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OSTEOARTHRITIS;

EID: 84927631951     PISSN: 10634584     EISSN: 15229653     Source Type: Journal    
DOI: 10.1016/j.joca.2014.07.024     Document Type: Review

References (82)

1. Thomas E., Peat G., Croft P. Defining and mapping the person with osteoarthritis for population studies and public health. Rheumatology (Oxford) 2014, 53:338-345.
2. Taieb C., Bruel P., Auges M. Knee arthritis: a confirmed burden. Osteoarthritis and Cartilage 2014, 22:S224-S225.
3. Jordan J.M., Kraus V.B., Hochberg M.C. Genetics of osteoarthritis. Curr Rheumatol Rep 2004, 6:7-13.
4. Kraus V.B., Jordan J.M., Doherty M., Wilson A.G., Moskowitz R., Hochberg M., et al. The genetics of generalized osteoarthritis (GOGO) study: study design and evaluation of osteoarthritis phenotypes. Osteoarthritis Cartilage 2007, 15:120-127.
5. Spector T.D., Cicuttini F., Baker J., Loughlin J., Hart D. Genetic influences on osteoarthritis in women: a twin study. BMJ 1996, 312:940-943.
6. Evangelou E., Kerkhof H.J., Styrkarsdottir U., Ntzani E.E., Bos S.D., Esko T., et al. Ameta-analysis of genome-wide association studies identifies novel variants associated with osteoarthritis of the hip. Ann Rheum Dis 2013, 10.1136/annrheumdis-2012-203114..
7. Panoutsopoulou K., Zeggini E. Advances in osteoarthritis genetics. JMed Genet 2013, 50:715-724.
8. Day-Williams A.G., Southam L., Panoutsopoulou K., Rayner N.W., Esko T., Estrada K., et al. Avariant in MCF2L is associated with osteoarthritis. Am J Hum Genet 2011, 89:446-450.
9. Evangelou E., Valdes A.M., Kerkhof H.J., Styrkarsdottir U., Zhu Y., Meulenbelt I., et al. Meta-analysis of genome-wide association studies confirms a susceptibility locus for knee osteoarthritis on chromosome 7q22. Ann Rheum Dis 2011, 70:349-355.
10. Kerkhof H.J., Lories R.J., Meulenbelt I., Jonsdottir I., Valdes A.M., Arp P., et al. Agenome-wide association study identifies an osteoarthritis susceptibility locus on chromosome 7q22. Arthritis Rheum 2010, 62:499-510.
11. Miyamoto Y., Mabuchi A., Shi D., Kubo T., Takatori Y., Saito S., et al. Afunctional polymorphism in the 5' UTR of GDF5 is associated with susceptibility to osteoarthritis. Nat Genet 2007, 39:529-533.
12. Valdes A.M., Evangelou E., Kerkhof H.J., Tamm A., Doherty S.A., Kisand K., et al. The GDF5 rs143383 polymorphism is associated with osteoarthritis of the knee with genome-wide statistical significance. Ann Rheum Dis 2011, 70:873-875.
13. Sanna S., Jackson A.U., Nagaraja R., Willer C.J., Chen W.M., Bonnycastle L.L., et al. Common variants in the GDF5-UQCC region are associated with variation in human height. Nat Genet 2008, 40:198-203.
14. Miyamoto Y., Shi D., Nakajima M., Ozaki K., Sudo A., Kotani A., et al. Common variants in DVWA on chromosome 3p24.3 are associated with susceptibility to knee osteoarthritis. Nat Genet 2008, 40:994-998.
15. Nakajima M., Takahashi A., Kou I., Rodriguez-Fontenla C., Gomez-Reino J.J., Furuichi T., et al. New sequence variants in HLA class II/III region associated with susceptibility to knee osteoarthritis identified by genome-wide association study. PLoS One 2010, 5:e9723.
16. Zeggini E., Panoutsopoulou K., Southam L., Rayner N.W., Day-Williams A.G., Lopes M.C., et al. Identification of new susceptibility loci for osteoarthritis (arcOGEN): a genome-wide association study. Lancet 2012, 380:815-823. arcOGEN Consortium, arcOGEN Collaborators,.
17. Castaño Betancourt M.C., Cailotto F., Kerkhof H.J., Cornelis F.M., Doherty S.A., Hart D.J., et al. Genome-wide association and functional studies identify the DOT1L gene to be involved in cartilage thickness and hip osteoarthritis. Proc Natl Acad Sci USA 2012, 109:8218-8223.
18. Evangelou E., Valdes A.M., Castano-Betancourt M.C., Doherty M., Doherty S., Esko T., et al. The DOT1L rs12982744 polymorphism is associated with osteoarthritis of the hip with genome-wide statistical significance in males. Ann Rheum Dis 2013, 72:1264-1265.
19. Lango Allen H., Estrada K., Lettre G., Berndt S.I., Weedon M.N., Rivadeneira F., et al. Hundreds of variants clustered in genomic loci and biological pathways affect human height. Nature 2010, 467:832-838.
20. Sovio U., Bennett A.J., Millwood I.Y., Molitor J., O'Reilly P.F., Timpson N.J., et al. Genetic determinants of height growth assessed longitudinally from infancy to adulthood in the northern Finland birth cohort 1966. PLoS Genet 2009, 5:e1000409.
21. Meulenbelt I., Min J.L., Bos S., Riyazi N., Houwing-Duistermaat J.J., van der Wijk H.J., et al. Identification of DIO2 as a new susceptibility locus for symptomatic osteoarthritis. Hum Mol Genet 2008, 17:1867-1875.
22. Castano Betancourt M., Evans D., Liu Y., Yau M., Uitterlinden A., Evangelou V., et al. Novel variants for cartilage thickness and hip osteoarthritis: revealing genes implicated in cartilage and bone development. Osteoarthritis and Cartilage 2014, 22:S41.
23. Yerges-Armstrong L.M., Yau M.S., Liu Y., Krishnan S., Renner J.B., Eaton C.B., et al. Association analysis of BMD-associated SNPs with knee osteoarthritis. JBone Min Res 2014, 29:1373-1379.
24. Rodriguez-Fontenla C., Calaza M., Evangelou E., Valdes A.M., Arden N., Blanco F.J., et al. Assessment of osteoarthritis candidate genes in a meta-analysis of nine genome-wide association studies. Arthritis Rheumatol 2014, 66:940-949.
25. Song G.G., Kim J.H., Lee Y.H. Ameta-analysis of the relationship between aspartic acid (D)-repeat polymorphisms in asporin and osteoarthritis susceptibility. Rheumatol Int 2014, 34:785-792.
26. Liu H., He H., Li S., Yang L., Wang P., Liu C., et al. Vitamin D receptor gene polymorphisms and risk of osteoarthritis: a meta-analysis. Exp Biol Med (Maywood) 2014, 239:559-567.
27. Zhu Z.H., Jin X.Z., Zhang W., Chen M., Ye D.Q., Zhai Y., et al. Associations between vitamin D receptor gene polymorphisms and osteoarthritis: an updated meta-analysis. Rheumatology (Oxford) 2014, 53:998-1008.
28. Panoutsopoulou K., Metrustry S., Doherty S.A., Laslett L.L., Maciewicz R.A., Hart D.J., et al. The effect of FTO variation on increased osteoarthritis risk is mediated through body mass index: a mendelian randomisation study. Ann Rheum Dis 2013; Feb 4, [Epub ahead of print]. 10.1136/annrheumdis-2013-203772..
29. Ruedel A., Stark K., Kaufmann S., Bauer R., Reinders J., Rovensky J., et al. N-cadherin promoter polymorphisms and risk of osteoarthritis. FASEB J 2014, 28:683-691.
30. Claessen K.M., Kloppenburg M., Kroon H.M., Bijsterbosch J., Pereira A.M., Romijn J.A., et al. Relationship between the functional exon 3 deleted growth hormone receptor polymorphism and symptomatic osteoarthritis in women. Ann Rheum Dis 2014, 73:433-436.
31. Vidal-Bralo L., Rodriguez-Fontela C., Calaza M., Oreiro N., Blanco F.J., Carr A., et al. New functional microsatellite associated with osteoarthritis susceptibility. Osteoarthritis and Cartilage 2014, 22:S232-S233.
32. Styrkarsdottir U., Thorleifsson G., Helgadottir H.T., Bomer N., Metrustry S., Bierma-Zeinstra S., et al. Severe osteoarthritis of the hand associates with common variants within the ALDH1A2 gene and with rare variants at 1p31. Nat Genet 2014, 46:498-502.
33. Boer C.G., Jv Rooij, Peters M., Kraaij R., Jhamai M., Arp P., et al. Discovery and analysis of rare coding variants for hipOA by exome-sequencing. Osteoarthritis and Cartilage 2014, 22:S226-S227.
34. Bos S.D., Bovee J.V., Duijnisveld B.J., Raine E.V., van Dalen W.J., Ramos Y.F., et al. Increased type II deiodinase protein in OA-affected cartilage and allelic imbalance of OA risk polymorphism rs225014 at DIO2 in human OA joint tissues. Ann Rheum Dis 2012, 71:1254-1258.
35. Bomer N., den Hollander W., Ramos Y.F., Bos S.D., van der Breggen R., Lakenberg N., et al. Underlying molecular mechanisms of DIO2 susceptibility in symptomatic osteoarthritis. Ann Rheum Dis 2014; Apr 2, [Epub ahead of print]. 10.1136/annrheumdis-2013-204739..
36. Syddall C.M., Reynard L.N., Young D.A., Loughlin J. The identification of trans-acting factors that regulate the expression of GDF5 via the osteoarthritis susceptibility SNP rs143383. PLoS Genet 2013, 9:e1003557.
37. Xu J., Liao L., Ning G., Yoshida-Komiya H., Deng C., O'Malley B.W. The steroid receptor coactivator SRC-3 (p/CIP/RAC3/AIB1/ACTR/TRAM-1) is required for normal growth, puberty, female reproductive function, and mammary gland development. Proc Natl Acad Sci USA 2000, 97:6379-6384.
38. Arimura A., vn Peer M., Schröder A.J., Rothman P.B. The transcriptional co-activator p/CIP (NCoA-3) is up-regulated by STAT6 and serves as a positive regulator of transcriptional activation by STAT6. JBiol Chem 2004, 279:31105-31112.
39. Nicholls J.J., Brassill M.J., Williams G.R., Bassett J.H. The skeletal consequences of thyrotoxicosis. JEndocrinol 2012, 213:209-221.
40. Rushton M.D., Gee F.H., Reynard L.N., Loughlin J. The osteoarthritis association marked by SNP rs6094710 mediates its effects by reducing the expression of NCOA3 in joint tissues. Osteoarthritis and Cartilage 2014, 22:S237.
41. Simopoulou T., Malizos K.N., Iliopoulos D., Stefanou N., Papatheodorou L., Ioannou M., et al. Differential expression of leptin and leptin's receptor isoform (Ob-Rb) mRNA between advanced and minimally affected osteoarthritic cartilage; effect on cartilage metabolism. Osteoarthritis and Cartilage 2007, 15:872-883.
42. Xu Y., Barter M.J., Swan D.C., Rankin K.S., Rowan A.D., Santibanez-Koref M., et al. Identification of the pathogenic pathways in osteoarthritic hip cartilage: commonality and discord between hip and knee OA. Osteoarthritis and Cartilage 2012, 20:1029-1038.
43. Gelse K., Ekici A.B., Cipa F., Swoboda B., Carl H.D., Olk A., et al. Molecular differentiation between osteophytic and articular cartilage-clues for a transient and permanent chondrocyte phenotype. Osteoarthritis and Cartilage 2012, 20:162-171.
44. Lambert C., Dubuc J.E., Montell E., Vergés J., Munaut C., Noël A., et al. Gene expression pattern of synovial cells from inflammatory and normal areas of osteoarthritis synovial membrane. Arthritis Rheum 2013, 66:960-968.
45. Schelbergen R.F., de Munter W., van den Bosch M.H., Lafeber F.P., Vogl T., Roth J., et al. Alarmins S100A8/S100A9 stimulate osteophyte formation in experimental osteoarthritis and predict osteophyte progression in the check cohort of early human osteoarthritis patients. Osteoarthritis and Cartilage 2014, 22:S303.
46. Remst D.F., Blom A.B., Vitters E.L., Bank R.A., van den Berg W.B., Blaney Davidson E.N., et al. Gene expression analysis of murine and human osteoarthritis synovium reveals elevation of transforming growth factor beta-responsive genes in osteoarthritis-related fibrosis. Arthritis Rheumatol 2014, 66:647-656.
47. Chou C.H., Wu C.C., Song I.W., Chuang H.P., Lu L.S., Chang J.H., et al. Genome-wide expression profiles of subchondral bone in osteoarthritis. Arthritis Res Ther 2013, 15:R190.
48. Ramos Y.F., Bos S.D., Lakenberg N., Böhringer S., den Hollander W.J., Kloppenburg M., et al. Genes expressed in blood link osteoarthritis with apoptotic pathways. Ann Rheum Dis 2013; Jul 17, [Epub ahead of print]. 10.1136/annrheumdis-2013-203405..
49. Oppermann U. Why is epigenetics important in understanding the pathogenesis of inflammatory musculoskeletal diseases?. Arthritis Res Ther 2013, 15:209.
50. Delgado-Calle J., Fernandez A.F., Sainz J., Zarrabeitia M.T., Sañudo C., García-Renedo R., et al. Genome-wide profiling of bone reveals differentially methylated regions in osteoporosis and osteoarthritis. Arthritis Rheum 2013, 65:197-205.
51. Cheung K.S., Hashimoto K., Yamada N., Roach H.I. Expression of ADAMTS-4 by chondrocytes in the surface zone of human osteoarthritic cartilage is regulated by epigenetic DNA de-methylation. Rheumatol Int 2009, 29:525-534.
52. da Silva M.A., Yamada N., Clarke N.M., Roach H.I. Cellular and epigenetic features of a young healthy and a young osteoarthritic cartilage compared with aged control and OA cartilage. JOrthop Res 2009, 27:593-601.
53. Roach H.I., Yamada N., Cheung K.S., Tilley S., Clarke N.M., Oreffo R.O., et al. Association between the abnormal expression of matrix-degrading enzymes by human osteoarthritic chondrocytes and demethylation of specific CpG sites in the promoter regions. Arthritis Rheum 2005, 52:3110-3124.
54. Bui C., Barter M.J., Scott J.L., Xu Y., Galler M., Reynard L.N., et al. cAMP response element-binding (CREB) recruitment following a specific CpG demethylation leads to the elevated expression of the matrix metalloproteinase 13 in human articular chondrocytes and osteoarthritis. FASEB J 2012, 26:3000-3011.
55. de Andres M.C., Imagawa K., Hashimoto K., Gonzalez A., Roach H.I., Goldring M.B., et al. Loss of methylation in CpG sites in the NF-kappaB enhancer elements of inducible nitric oxide synthase is responsible for gene induction in human articular chondrocytes. Arthritis Rheum 2013, 65:732-742.
56. Hashimoto K., Otero M., Imagawa K., de Andres M.C., Coico J.M., Roach H.I., et al. Regulated transcription of human matrix metalloproteinase 13 (MMP13) and interleukin-1beta (IL1B) genes in chondrocytes depends on methylation of specific proximal promoter CpG sites. JBiol Chem 2013, 288:10061-10072.
57. Scott J.L., Gabrielides C., Davidson R.K., Swingler T.E., Clark I.M., Wallis G.A., et al. Superoxide dismutase downregulation in osteoarthritis progression and end-stage disease. Ann Rheum Dis 2010, 69:1502-1510.
58. Fernández-Tajes J., Soto-Hermida A., Vázquez-Mosquera M.E., Cortés-Pereira E., Mosquera A., Fernández-Moreno M., et al. Genome-wide DNA methylation analysis of articular chondrocytes reveals a cluster of osteoarthritic patients. Ann Rheum Dis 2014, 73:668-677.
59. Ito S., Shen L., Dai Q., Wu S.C., Collins L.B., Swenberg J.A., et al. Tet proteins can convert 5-methylcytosine to 5-formylcytosine and 5-carboxylcytosine. Science 2011, 333:1300-1303.
60. Taylor S.E., Smeriglio P., Dhulipala L., Rath M., Bhutani N. Aglobal increase in 5-hydroxymethylcytosine levels marks osteoarthritic chondrocytes. Arthritis Rheum 2014, 66:90-100.
61. den Hollander W., Ramos Y.F., Bos S.D., Bomer N., van der Breggen R., Lakenberg N., et al. Genome wide DNA methylation profiling of osteoarthritic articular cartilage. Osteoarthritis and Cartilage 2014, 22:S40-S41.
62. Rushton M.D., Reynard L.N., Barter M.J., Rankin K.S., Young D.A., Loughlin J. Characterisation of the cartilage DNA methylome in knee and hip osteoarthritis using high-density genome-wide analysis. Osteoarthritis and Cartilage 2014, 22:S233.
63. Bartel D.P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004, 116:281-297.
64. Iliopoulos D., Malizos K.N., Oikonomou P., Tsezou A. Integrative microRNA and proteomic approaches identify novel osteoarthritis genes and their collaborative metabolic and inflammatory networks. PLoS One 2008, 3:e3740.
65. Jones S.W., Watkins G., Le Good N., Roberts S., Murphy C.L., Brockbank S.M., et al. The identification of differentially expressed microRNA in osteoarthritic tissue that modulate the production of TNF-alpha and MMP13. Osteoarthritis and Cartilage 2009, 17:464-472.
66. Díaz-Prado S., Cicione C., Muiños-López E., Hermida-Gómez T., Oreiro N., Fernández-López C., et al. Characterization of microRNA expression profiles in normal and osteoarthritic human chondrocytes. BMC Musculoskelet Disord 2012, 13:144.
67. Miyaki S., Nakasa T., Otsuki S., Grogan S.P., Higashiyama R., Inoue A., et al. MicroRNA-140 is expressed in differentiated human articular chondrocytes and modulates interleukin-1 responses. Arthritis Rheum 2009, 60:2723-2730.
68. Tuddenham L., Wheeler G., Ntounia-Fousara S., Waters J., Hajihosseini M.K., Clark I., et al. The cartilage specific microRNA-140 targets histone deacetylase 4 in mouse cells. FEBS Lett 2006, 580:4214-4217.
69. Nakamura Y., Inloes J.B., Katagiri T., Kobayashi T. Chondrocyte-specific microRNA-140 regulates endochondral bone development and targets Dnpep to modulate bone morphogenetic protein signaling. Mol Cell Biol 2011, 31:3019-3028.
70. Liang Z.J., Zhuang H., Wang G.X., Li Z., Zhang H.T., Yu T.Q., et al. MiRNA-140 is a negative feedback regulator of MMP-13 in IL-1beta-stimulated human articular chondrocyte C28/I2 cells. Inflamm Res 2012, 61:503-509.
71. Akhtar N., Rasheed Z., Ramamurthy S., Anbazhagan A.N., Voss F.R., Haqqi T.M. MicroRNA-27b regulates the expression of matrix metalloproteinase 13 in human osteoarthritis chondrocytes. Arthritis Rheum 2010, 62:1361-1371.
72. Tardif G., Hum D., Pelletier J.P., Duval N., Martel-Pelletier J. Regulation of the IGFBP-5 and MMP-13 genes by the microRNAs miR-140 and miR-27a in human osteoarthritic chondrocytes. BMC Musculoskelet Disord 2009, 10:148.
73. Li J., Huang J., Dai L., Yu D., Chen Q., Zhang X., et al. miR-146a, an IL-1beta responsive miRNA, induces vascular endothelial growth factor and chondrocyte apoptosis by targeting Smad4. Arthritis Res Ther 2012, 14:R75.
74. Yamasaki K., Nakasa T., Miyaki S., Ishikawa M., Deie M., Adachi N., et al. Expression of MicroRNA-146a in osteoarthritis cartilage. Arthritis Rheum 2009, 60:1035-1041.
75. Wang J.H., Shih K.S., Wu Y.W., Wang A.W., Yang C.R. Histone deacetylase inhibitors increase microRNA-146a expression and enhance negative regulation of interleukin-1beta signaling in osteoarthritis fibroblast-like synoviocytes. Osteoarthritis and Cartilage 2013, 21:1987-1996.
76. Matsukawa T., Sakai T., Yonezawa T., Hiraiwa H., Hamada T., Nakashima M., et al. MicroRNA-125b regulates the expression of aggrecanase-1 (ADAMTS-4) in human osteoarthritic chondrocytes. Arthritis Res Ther 2013, 15:R28.
77. Park S.J., Cheon E.J., Kim H.A. MicroRNA-558 regulates the expression of cyclooxygenase-2 and IL-1β-induced catabolic effects in human articular chondrocytes. Osteoarthritis and Cartilage 2013, 21:981-989.
78. Park S.J., Cheon E.J., Lee M.H., Kim H.A. MicroRNA-127-5p regulates matrix metalloproteinase 13 expression and interleukin-1beta-induced catabolic effects in human chondrocytes. Arthritis Rheum 2013, 65:3141-3152.
79. Vonk L.A., Kragten A.H., Dhert W.J., Saris D.B., Creemers L.B. Overexpression of hsa-miR-148a promotes cartilage production and inhibits cartilage degradation by osteoarthritic chondrocytes. Osteoarthritis and Cartilage 2014, 22:145-153.
80. Zhang Y., Jia J., Yang S., Liu X., Ye S., Tian H. MicroRNA-21 controls the development of osteoarthritis by targeting GDF-5 in chondrocytes. Exp Mol Med 2014, 46:e79.
81. Le L., Swingler T.E., Crowe N., Driscoll C., Vincent T.L., Barter M.J., et al. The microRNA-29 family in osteoarthritis. Osteoarthritis and Cartilage 2014, 22:S41-S42.
82. Beyer C., Zampetaki A., Lin N.Y., Kleyer A., Perricone C., Iagnocco A., et al. Signature of circulating microRNAs in osteoarthritis. Ann Rheum Dis 2014; Feb 27, [Epub ahead of print]. 10.1136/annrheumdis-2013-204698.